Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results
(NASDAQ: FULC) Delayed: 3.72 -0.02 (0.53%)
Previous Close $3.74    52 Week High $ 
Open $3.75    52 Week Low $ 
Day High $3.76    P/E N/A 
Day Low $3.71    EPS $ 
Volume 901,245